Omforro

उत्पाद अवलोकन

About Omforro

Omforro was developed as a medicine for conscious sedation (to calm or make people sleepy) before or during diagnostic or surgical procedures where the patient remains awake (conscious sedation). It was also intended for use as premedication before anaesthesia. It was to be used in adults and children from 2 years of age.

What it is used for

Omforro was developed as a medicine for conscious sedation (to calm or make people sleepy) before or during diagnostic or surgical procedures where the patient remains awake (conscious sedation). It was also intended for use as premedication before anaesthesia.

How it is used

Omforro contains the active substance midazolam and was to be available as a nasal spray.

How it works

The active substance in Omforro, midazolam, belongs to a class of sedative medicines called benzodiazepines. It attaches to receptors (targets) for the neurotransmitter gamma-amino butyric acid (GABA) in the brain and activates them. Neurotransmitters such as GABA are chemicals that allow nerve cells to communicate with each other. In the brain, GABA is involved in reducing the electrical activity. By activating the GABA receptors, midazolam slows down brain activity, which makes the person feel relaxed and sleepy. The extent of the effects of Omforro on brain activity depends on the dose given and the other medicines used during the procedure.

Active substance: midazolam

Source: EMA EPAR